Fitness & Wellness Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness & Wellness Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hyperhomocysteinemia
Studies from A.P. Singh et al add new findings in the area of hyperhomocysteinemia
August 20th, 2008
According to a study from India, "The present study has been designed to investigate the effect of sodium cromoglyeate and ketotifen, mast cell stabilizers in hyperhomocystememia-induced cardiac hypertrophy in rats. Rats were administered L-methionine (1.7 g/kg/day PO) for 8 weeks to produce hyperhomocysteinemia." "Sodium cromoglycate (24 mg/kg/day IP) and ketotifen (1mg/kg/day IP) treatments were started from first day of administration of L-methionine and continued for 8 weeks. The development of cardiac hypertrophy was assessed in terms of measuring mean arterial blood pressure (MABP), ratio of left ventricular (LV) weight to body weight (LVW/BW), LV wall thickness...
Source: Fitness & Wellness Business Week (2008-08-20)
|
